Brockman a former head of the drug resistance section of the southern research institute completed an approximately 100page book chapter describing in detail the knowledge of anticancer drug resistance mechanisms at that time. Unfortunately, the small number of patients in these studies limits their significance 4. Pdf mechanisms of drug resistance in cancer chemotherapy. Although on the surface cell confluence seems like it could be an irrelevant. Drug resistance and combating drug resistance in cancer. The cross resistance to different cytotoxic regiments in tumor cells because of failure of activation of caspases. Drug resistance to cytotoxic nucleoside analogues bentham. Drug refractoriness represents a problem in oncology and little is known about the molecular basis underlying resistance. Clinical importance of specific mechanisms of drug resistance as can be seen from the evidence previously presented, the significance that specific drugresistance mechanisms play in the clinical response of tumors to cytotoxic agents is unclear. The breast 1996 5, 293297 1996 pearson professional ltd eso task force article mechanisms of cytotoxic drug resistance in breast cancer d. Resistance mechanisms were investigated in 5 patients resistant to lorlatinib. There are many problems in the cancer therapy, such as cytotoxic agents resistance and toxic chemotherapy. The different mechanisms of cancer drug resistance. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energydependent transporters that detect and eject anticancer drugs from cells, but other mechanisms of resistance including insensitivity to druginduced apoptosis and induction of drugdetoxifying mechanisms probably play an important role in acquired anticancer drug resistance.
Molecular mechanisms of drug resistance longley 2005. Expression of a major vault protein, termed lung resistancerelated protein lrp, which may regulate. At present, the research on the mechanisms of drug resistance in aml is very active. Brown in pdf or epub format and read it directly on your mobile phone, computer or any device. This poor prognosis largely results from resistance to conventional chemotherapy, namely cytotoxic drugs. Mechanisms of drug resistance in cancer chemotherapy. More often than not, intrinsic or acquired resistance of tumour cells to cytotoxic drugs renders such treatment ineffective. Mechanisms of resistance to antibodydrug conjugates. Describe the specific mechanisms of action, causes of drug resistance and toxicities associated with the drugs presented. Most of this under standing has come from studies on tumor cells made resistant in vitro, but there is reason to. Resistance constitutes a lack of response to drug induced tumour growth inhibition. Once a cancer has developed resistance to one type of drug, it is more likely to develop resistance to.
The degree of intrinsic drug resistance predetermines the sensitivity of given cancer cells to a specific drug. Overcoming chemoresistance has been extensively studied within the past, especially using cddpresistant cells. However, the acquisition of drug resistance is a major clinical problem and is perhaps the main limiting factor in successful treatment of cancer. In cytotoxic drug resistance mechanisms, leading clinical and laboratory scientists describe cuttingedge methods for examining the mechanisms of cellular resistance to anticancer cytotoxics in. There has been a considerable advance in our understanding of the biochemical mechanisms responsible for conferring antineoplastic drug resistance in breast cancer. This article will elaborate on the main mechanisms of drug resistance currently being studied, including drug resistancerelated proteins and enzymes, gene alterations, micro rnas, and signal pathways. Hypoxiainduced cytotoxic drug resistance in osteosarcoma is. A mechanism for overcoming pglycoproteinmediated drug. For the past 40 years, researchers have been tabulating the various mechanisms by which cancer cells grown in tissue culture become resistant to anticancer drugs figure 1.
Modulation of the efficiency of the coupling of drug induced damage to the activation of apoptosis is a key mechanism of drug resistance. Cytotoxic therapy is still the backbone of effective chemotherapy, although most current pharmaceutical interest is in targeted therapy. Cytotoxic drug resistance in hypoxia is dependent upon functional hif1 in a number of different tumour cell types. Chemotherapy resistance sometimes develops over time as the tumors adapt and can overcome the toxicity of the chemo medication. Figure 1ai, is resistance caused by drugresistance pumps, for example. Their main cytotoxic action is mediated through an inhibitory effect on topoisomerase ii, the activity of which is markedly increased in proliferating cells. Figure 1ai, is resistance caused by drug resistance pumps, for example, pglycoprotein pgp. Studies on mechanisms of cancer drug resistance have yielded important information about how. Find, read and cite all the research you need on researchgate. However, the acquisition of drug resistance is a major clinical problem and is perhaps the main limiting factor in successful treatment. Dr can be either intrinsic or acquired, and although the development and clinical implications are different, the underlying mechanisms are likely to be similar. These cover a wide range of techniques applicable to the usual molecular suspects, including pglycoprotein and related drug transporters, p53, the bcl2 family, and glutathione conjugation.
Often, if a cancer becomes resistant to one drug or group of drugs, it. However, the acquisition of drug resistance is a major clinical problem and is. The resistance mechanism is called typical or classical. O6benzylguanine sensitize healthy cells to cytotoxic drugs 54,59,60. Pdf on feb 1, 2000, chris norbury and others published cytotoxic drug resistance mechanisms. Evs can mediate drug resistance by several mechanisms. Drug resistance antimicrobial resistance is the reduction in effectiveness of a drug in curing a disease.
It is thought that this may reduce the incidence of developing resistance to any one drug. Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc. Development of chemoresistance is a persistent problem during the chemotherapy treatment. Overall, drug inactivation is a mechanism of cancer drug resistance. Circumventing cancer drug resistance in the era of.
Nih funding opportunities and notices in the nih guide for grants and contracts. Antibiotic resistance is the ability of bacteria to resist the effect of an. The crossresistance to different cytotoxic regiments in tumor cells because of failure of activation of caspases. They can act as decoys carrying membrane proteins and capturing monoclonal. Cytotoxic drugs include drugs used to treat cancer and in some cases, to treat certain skin conditions e. Cytotoxic drug resistance mechanisms robert brown springer. Full text mechanisms of drug resistance in acute myeloid. Hence, diverse therapies are used to attack cancer, including cytotoxic and targeted agents.
Hif1 is the major factor in hypoxiainduced drug resistance. The control of apoptosis and drug resistance in ovarian cancer. As the introductory chapter points out, it is often difficult to attribute clinical observations of drug resistance to any one of these high profile mechanisms. Drug resistance dr is the major limiting factor in the successful treatment of systemic neoplasia with cytotoxic chemotherapy. While a spontaneous or induced genetic mutation in bacteria may confer resistance to antimicrobial drugs, genes that confer. The mechanisms of resistance are incompletely understood, but mechanisms limiting the binding of trastuzumab to cancer cells may be involved. Chemotherapy often abbreviated to chemo and sometimes ctx or ctx is a type of cancer treatment that uses one or more anticancer drugs chemotherapeutic agents as part of a standardized chemotherapy regimen. Mechanisms of cancer drug resistance and sensitivity u54 rfaca17009. The basis for drug resistance in melanoma is most likely dysregulation of apoptosis, although other mechanisms including drug transport, detoxification, and enhanced dna repair may also play a role. This guide explains the duty of an employer in a health care facility to protect workers who are likely to be exposed to cytotoxic drugs.
This book aims to equip those involved in basic and translational research with a repertoire of experimental approaches to this problem of anticancer drug resistance. O6 benzylguanine sensitize healthy cells to cytotoxic drugs 54,59,60. The protocols contain detailed instructions and extensive troubleshooting tips that allow researchers. Mechanisms of drug resistance in veterinary oncology a. Hyperthermia has also been shown to help prevent or reverse chemo resistance. Mechanisms of cytotoxic drug resistance in breast cancer 297 15. Antibodydrug conjugates adc are biotherapeutics designed to deliver potent cytotoxins to cancer cells via tumor. Sep 23, 2017 evs can mediate drug resistance by several mechanisms. Defects in the activation of the caspase3 proteolytic. Drug resistance can occur at many levels, including increased drug efflux, drug inactivation, alterations in drug target, processing. Hippo pathway mediates resistance to cytotoxic drugs pnas. Diverse resistance mechanisms to the thirdgeneration alk.
However, the acquisition of drug resistance is a major clinical problem and is perhaps the main. The aim of cytotoxic drug resistance mechanisms is to provide pro cols that are appropriate for examining the mechanisms of cellular. The second cytotoxic drug could have an alternative nontubulin mechanism of action 39. Cytotoxic antibiotics, such as the anthracyclines doxorubicin, idarubicin, daunorubicin, epirubicin, aclarubicin, mitoxantrone bind to dna and inhibit both dna and rna synthesis 16. Drug resistance limits the effectiveness of cancer therapies. Be able to classify these particular agents according to 1 chemical class, 2 mechanism of action, 3 cell cycle specificity, 4 therapeutic uses, and 5 major toxicities. Sclc is heterogenous for the majority of studied markers, most likely also involving the mechanisms for drug resistance. Cytotoxic drugs that selectively, but not exclusively, target actively proliferating cells include such diverse groups as dnaalkylating agents, antimetabolites, intercalating agents and mitotic inhibitors. The basis for drug resistance in melanoma is most likely dysregulation of apoptosis, although other mechanisms including drug transport, detoxification, and. Cytotoxic drugs include any drug that inhibits or prevents the function of cells. Kerr crc institute for cancer studies, university of birmingham, birmingham, uk s u m m a r y. Principal mechanisms may include altered membrane transport involving the pglycoprotein product of the multidrug resistance mdr gene as well as other associated proteins, altered target enzyme e. For tdm1, some resistance mechanisms could overlap with those that apply for the cytotoxic agent carried by the adc or for trastuzumab, but can also be unique to the adc form. Once a cancer has developed resistance to one type of drug, it is more likely to develop resistance to other drugs, making treatment more difficult.
Lorlatinib is a thirdgeneration anaplastic lymphoma kinase alk tyrosine kinase inhibitor with proven efficacy in patients with alkrearranged lung cancer previously treated with first and secondgeneration alk inhibitors. Modification of the cytotoxic drug moiety since the. Ironi cally, some of the mechanisms that could be utilised by cancer cells to resist cytotoxic drugs are probably evolved in normal cells as a. Drug resistance and apoptosis university of florida. Our findings concern a general adaptive response of cells that causes resistance to gemcitabine and 15 other fdaapproved cytotoxic drugs when cells are grown at high density. Mechanisms of acquired drug resistance can be totally different from the preexisting intrinsic drug resistance.
Unfortunately, various resistance mechanisms decrease the activity of these drugs, reducing their clinical efficacy. Study uncovers novel relationships between slcs and. Hypoxiainduced cytotoxic drug resistance in osteosarcoma. The protocols contain detailed instructions and extensive troubleshooting tips. A major limitation of the cytotoxic chemotherapeutic, doxorubicin dox. There is now a range of cytotoxic drugs that have considerable clinical usefulness in producing responses in tumors and even, in a small proportion of cases, cure. Despite attempts to develop curative anticancer treatments, tumors evolve evasive mechanisms limiting durable responses.
Longitudinal tumor biopsies were studied using highthroughput nextgeneration sequencing. Patientderived models were developed to characterize the acquired resistance mechanisms, and baf3 cell mutants were generated to study the effect of novel alk compound mutations. Most causes for dr are pharmacodynamic in nature, result from adaptations within the tumor cell and. In cytotoxic drug resistance mechanisms, leading clinical and laboratory. In order to combat resistance, chemotherapy drugs are often given in combination in the hopes that the cancer will fail to resist at least one of the drugs in the combination. Some of these mechanisms, such as loss of a cell surface receptor or.
When the drug is not intended to kill or inhibit a pathogen, then the term is equivalent to dosage failure or drug tolerance. The development of drug resistance is one reason that drugs are often given in combination. Alternatively, it can be a selective expansion of the intrinsic drug resistance. Modulation of the efficiency of the coupling of druginduced damage to the activation of apoptosis is a key mechanism of drug resistance. They can act as decoys carrying membrane proteins and capturing monoclonal antibodies intended to target receptors at the cell surface. They target rapidly proliferating cells with the aim of causing a lethal cytotoxic event or apoptosis in order to arrest tumour development. Download the ebook cytotoxic drug resistance mechanisms r.
Cytotoxic drug resistance mechanisms methods in molecular. Both clinical and experimental aspects of drug resistance in cancer are included. Cytotoxic drug resistance mechanisms pdf free download. Alternative strategies include binding of another cytotoxic drug in addition to dm1 to trastuzumab, or administering another adc in combination with tdm1, such as a cytotoxic drug linked to pertuzumab. Indeed, given that many of the cytotoxic anticancer drugs were discovered by random screening, it is clear what features give a clinically useful anticancer drug a sufficient the peutic index to be of value. May 02, 2017 cytotoxic therapy is still the backbone of effective chemotherapy, although most current pharmaceutical interest is in targeted therapy. A major obstacle in treatment of sclc patients is the fact that almost all patients will develop a reduced response to cytotoxic drugs. Mechanisms for acquired cytotoxic drug resistance in human. Cytotoxic chemotherapeutic agents are unlike most drugs, as they dont target specific proteins, but instead a property of the cell. Resistance constitutes a lack of response to druginduced tumour growth inhibition.
223 343 316 1121 899 477 139 1568 832 1550 577 1002 1467 730 330 3 60 1430 102 120 840 146 455 835 527 1565 20 1192 778 675 74 1296 133 281 1173 1212 760 569 193 864 17 941 1135 1346 1023 490 1408 254 160